NCT00128700View on ClinicalTrials.gov

Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

November 30, 2007

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

temozolomide

DRUG

vatalanib

PROCEDURE

adjuvant therapy

RADIATION

radiation therapy

Trial Locations (5)

35128

Azienda Ospedaliera di Padova, Padua

B-3000

U.Z. Gasthuisberg, Leuven

D-93053

Klinikum der Universitaet Regensburg, Regensburg

3075 EA

Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00128700 - Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter